Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Advisory Committees

February 25, 2011: Vaccines and Related Biological Products Advisory Committee Meeting Draft Agenda

DoubleTree Hotel Bethesda and Executive Meeting Center
8120 Wisconsin Ave., Bethesda, MD 20814
February 25, 2011

DRAFT AGENDA

Topic: Strain Selection for the Influenza Virus Vaccine for the 2011-2012 Season

8:30 a.m.
Call to OrderChair
8:35
Administrative RemarksDon Jehn, M.S., FDA
8:45
IntroductionJerry Weir, Ph.D., FDA
8:55
U.S. Surveillance

Lisa Grohskopf, M.D., CDC

9:15
World Surveillance/Virus CharacterizationNancy Cox, Ph.D., CDC
10:00
DoD Vaccine Effectiveness ReportKevin Russell, M.D., DOD
10:20
Break 
10:35
Vaccine Responses

Zhiping Ye, M.D., Ph.D., FDA

10:55
Availability of Vaccine Viruses & ReagentsWilliam McCormick, Ph.D., FDA
11:10
Comments from Manufacturers

Samson Lee, Ph.D.,
Sanofi Pasteur

11:30

Update on H5N1 and H9N2 Surveillance and Virus Characterization

Nancy Cox, Ph.D., CDC
11:50
Open Public Hearing 
12:50
Committee Discussion and Recommendations 
1:50
Adjourn for the Day 

Page Last Updated: 08/11/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English